Taiwan FDA registration 21da739a2f2eb42b7b9e732832b37ea4

Cimosir protein S reagent

TW: 希摩西爾蛋白S試劑
Taiwan flagTaiwan·Risk Class 2·INSTRUMENTATION LABORATORY CO.·Registered Mar 31, 2006 – Mar 31, 2016Cancelled
Registration details
Analysis ID
21da739a2f2eb42b7b9e732832b37ea4
Customs Code
DHA00601628400
Company information
Manufacturer Country
United States
Authorized Representative
GRANT TECHNOLOGY CO., LTD.
Product details
Intended Use
The concentration of Protein S in human citric plasma is determined by colorimetric method in the IL blood coagulation instrument system.
Product Type (Level 1)
B Hematology, pathology, and genetics
Product Type (Level 2)
B.5425 Versatile system for in vitro agglutination studies
Dates and status
Registration Date
Mar 31, 2006
Expiry Date
Mar 31, 2016
Cancellation Date
May 10, 2018
Cancellation information
Status
Logged out
Reason
許可證已逾有效期
Companies making similar products

Top companies providing products similar to "Cimosir protein S reagent"

Recent registrations

Recently registered similar products

About this record

Access comprehensive regulatory information for Cimosir protein S reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 21da739a2f2eb42b7b9e732832b37ea4 and manufactured by INSTRUMENTATION LABORATORY CO.. The authorized representative in Taiwan is GRANT TECHNOLOGY CO., LTD..

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including INSTRUMENTATION LABORATORY CO., and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices1 Competitors1 Recent Registrations